Embremma Injection
Manufacturer
Emcure Pharmaceuticals Ltd
Salt Composition
Eribulin Mesylate (0.5mg/ml)
Key Information
Short Description
Embremma Injection is used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other anticancer medicines after the cancer has spread.
Dosage Form
Injection
Introduction
Embremma Injection can be used on its own or sometimes given together with certain other medicines as part of combination chemotherapy. It is given as injection under the supervision of doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Directions for Use
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
How it works
Embremma Injection is an anticancer medication. It works by interfering with the microtubule structures which help the cancer cells to divide and multiply. This blocks the growth cycle (cell cycle) of cancer cells and eventually kills them.
Quick Tips
Embremma Injection helps treat breast cancer that has spread to other areas of the body. It is given by an injection into a vein (intravenously). It may cause dizziness and tiredness. Do not drive or do anything requiring concentration until you know how it affects you. Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for three months after you stop taking it. Your doctor may get regular blood tests done to monitor your blood cells and electrolyte levels during treatment with this medicine. Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea while taking this medicine. It may cause numbness, tingling or pricking sensations in your hands and feet. Inform your doctor if this bothers you.
Frequently asked questions
Is hair loss caused by Embremma Injection irreversible?
Hair loss is a common side effect of Embremma Injection. The severity of hair loss can vary, and its reversibility depends on the individual. Consult your doctor if you have concerns regarding hair loss.
How long can I stay on Embremma Injection?
Embremma Injection is typically administered once a week for up to 21 days, as per a recommended cycle. The duration of treatment depends on individual needs and will be determined by your doctor based on factors such as blood test results and response to treatment. The exact dosage and administration may vary based on these factors.
How is Embremma Injection Mesylate administered?
Embremma Injection will be given to you by a doctor or healthcare professional as an intravenous injection, usually over 2 to 5 minutes. The exact dose will depend on your body surface area (measured in square meters, or m2), which is calculated based on your weight and height. Your doctor may adjust the dose depending on your blood test results. To ensure a complete dose administration, it's recommended to flush a saline solution into the vein after receiving Embremma Injection.
What are the serious side effects of Embremma Injection?
Embremma Injection can cause serious side effects, including low white blood cell count (neutropenia). This could lead to serious infections and potential death. It can also cause numbness, tingling, or pain in your hands or feet (peripheral neuropathy), which is common with Embremma Injection and may be severe. However, it's important to note that this medication can cause harm to a developing baby if taken by pregnant women.
When can I plan a pregnancy if I am using Embremma Injection?
Women of childbearing age should use effective contraception during and up to 3 months after treatment with Embremma Injection. It may cause serious birth defects and should not be used if you are pregnant unless it's thought clearly necessary after careful consideration of all risks for both you and the baby.
What precautions should be followed while handling Embremma Injection?
When handling Embremma Injection, it is crucial to take proper precautions. Avoid any contact with skin, eyes, mouth, and the inside of your nose. To ensure safe handling, wear gloves, goggles, and protective clothing. If skin comes into contact with the solution, wash thoroughly with soap and water. Similarly, if your eyes, mouth, or nose come in contact with Embremma Injection, flush the area thoroughly with water. Pregnant staff should not handle Embremma Injection.
In which solution should Embremma Injection injection be diluted?
Embremma Injection may be diluted in up to 100 ml of sodium chloride 9 mg/ml (0.9%) solution, but not in 5% dextrose. It should only be administered under the supervision of a physician experienced in administering cancer chemotherapy and by a healthcare professional.
